A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer-Reference-Cited by-同舟云学术

A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer

Published:2010-12-13 Issue:2 Volume:186 Page:685-696
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Chinnasamy Nachimuthu,Wargo Jennifer A.,Yu Zhiya,Rao Mahadev,Frankel Timothy L.,Riley John P.,Hong Jenny J.,Parkhurst Maria R.,Feldman Steven A.,Schrump David S.,Restifo Nicholas P.,Robbins Paul F.,Rosenberg Steven A.,Morgan Richard A.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference62 articles.

1. Cancer Immunotherapy: A Treatment for the Masses

2. A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens

3. Adoptive cell transfer: a clinical path to effective cancer immunotherapy

4. Progress in human tumour immunology and immunotherapy

5. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rebirth of epitope-based patent claims;Human Antibodies;2024-06-11

2. Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy;Experimental Hematology & Oncology;2024-04-03

3. Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential;Cancers;2023-12-26

4. T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome;Nature Reviews Drug Discovery;2023-10-27

5. Evolution by innovation as a driving force to improve TCR-T therapies;Frontiers in Oncology;2023-09-21